To include your compound in the COVID-19 Resource Center, submit it here.

Report: Activist investor pressing Alexion for changes

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) gained $7.68 to $114.46 on Friday after media reports said activist shareholder Elliott Management is urging the company to take measures to boost its share price. According to a New York Times report,

Read the full 376 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE